4.5 Article

AB051. P-19. A phase II study of infigratinib (BGJ398) in previously-treated advanced cholangiocarcinoma containing FGFR2 fusions

Journal

HEPATOBILIARY SURGERY AND NUTRITION
Volume 8, Issue S1, Pages AB051-AB051

Publisher

AME Publishing Company
DOI: 10.21037/hbsn.2019.ab051

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available